Skip to main content

Journal of Neuro-Oncology

Ausgabe 1/2014

Inhalt (29 Artikel)

Topic Review

Brain metastasis from ovarian cancer: a systematic review

Shabnam Pakneshan, Damoun Safarpour, Fattaneh Tavassoli, Bahman Jabbari

Topic Review

Diffuse intrinsic pontine glioma: a reassessment

Nathan J. Robison, Mark W. Kieran

Laboratory Investigation

Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations

Ahsan S. Farooqi, Rebecca A. Dagg, L. Mi Rim Choi, Jerry W. Shay, C. Patrick Reynolds, Loretta M. S. Lau

Laboratory Investigation

Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme

Malini Mukherjee, Tiara Byrd, Vita S. Brawley, Kevin Bielamowicz, Xiao-Nan Li, Fatima Merchant, Saurabh Maitra, Pavel Sumazin, Greg Fuller, Yvonne Kew, David Sun, Suzanne Z. Powell, Nabil M. Ahmed, Nenggang Zhang, Debananda Pati

Erratum

Erratum to: Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme

Malini Mukherjee, Tiara Byrd, Vita S. Brawley, Kevin Bielamowicz, Xiao-Nan Li, Fatima Merchant, Saurabh Maitra, Pavel Sumazin, Greg Fuller, Yvonne Kew, David Sun, Suzanne Z. Powell, Nabil Ahmed, Nenggang Zhang, Debananda Pati

Laboratory Investigation

The overexpression of Epithelial cell adhesion molecule (EpCAM) in glioma

Xin Chen, Wei-Yuan Ma, Shang-Chen Xu, Yu Liang, Yi-Bing Fu, Bo Pang, Tao Xin, Hai-Tao Fan, Rui Zhang, Jian-Gang Luo, Wen-Qing Kang, Min Wang, Qi Pang

Laboratory Investigation

FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation

Lei Hua, Ming Zhu, Xu Song, Jun Wang, Zhen Fang, Chunting Zhang, Qiong Shi, Wenjian Zhan, Lei Wang, Qingming Meng, Xiuping Zhou, Rutong Yu

Laboratory Investigation

CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage

Úrsula Urias, Suely K. N. Marie, Miyuki Uno, Roseli da Silva, Mariá M. Evagelinellis, Otavia L. Caballero, Brian J. Stevenson, Wilson A. Silva Jr., Andrew J. Simpson, Sueli M. Oba-Shinjo

Laboratory Investigation

1p34.2 rs621559 and 14q21 rs398652 leukocyte telomere length-related genetic variants contribute to glioma susceptibility

Yi-Dong Chen, Chao Lu, Jinyu Wei, Sichong Han, Herui Wang, Tao Jiang, Xiao-Guang Qiu, Ming Yang

Open Access Laboratory Investigation

The proteomic response in glioblastoma in young patients

Ruth F. Deighton, Thierry Le Bihan, Sarah F. Martin, Martin E. Barrios-Llerena, Alice M. J. Gerth, Lorraine E. Kerr, James McCulloch, Ian R. Whittle

Laboratory Investigation

Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction

Xing-Qi Li, Zhi-Gang Ouyang, Sheng-Hua Zhang, Hong Liu, Yue Shang, Yi Li, Yong-Su Zhen

Clinical Study

Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis

Shingo Yonezawa, Kazuhiro Miwa, Jun Shinoda, Yuichi Nomura, Yoshitaka Asano, Noriyuki Nakayama, Naoyuki Ohe, Hirohito Yano, Toru Iwama

Clinical Study

Spin-echo echo-planar perfusion prior to chemoradiation is a strong independent predictor of progression-free and overall survival in newly diagnosed glioblastoma

Ayca Akgoz, Rifaquat Rahman, Hui You, Jinrong Qu, Alhafidz Hamdan, Ravi T. Seethamraju, Patrick Y. Wen, Geoffrey S. Young

Clinical Study

Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study

Seil Sohn, Chun Kee Chung, Moon Jun Sohn, Ung-Kyu Chang, Sung Hwan Kim, Jinhee Kim, Eunjung Park

Clinical Study

EMPACT syndrome: limited evidence despite a high-risk cohort

Andrew J. Bishop, Maria Chang, Mario E. Lacouture, Christopher A. Barker

Clinical Study

Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma

Mohamed A. Hamza, Jacob J. Mandel, Charles A. Conrad, Mark R. Gilbert, W. K. Alfred Yung, Vinay K. Puduvalli, John F. DeGroot

Clinical Study

Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab

Rifaquat Rahman, Alhafidz Hamdan, Rebecca Zweifler, Han Jiang, Andrew D. Norden, David A. Reardon, Srinivasan Mukundan, Patrick Y. Wen, Raymond Y. Huang

Clinical Study

Stereotactic radiosurgery of petroclival meningiomas: a multicenter study

Robert Starke, Hideyuki Kano, Dale Ding, Peter Nakaji, Gene H. Barnett, David Mathieu, Veronica Chiang, James B. Yu, Judith Hess, Heyoung L. McBride, Norissa Honea, John Y. K. Lee, Gazanfar Rahmathulla, Wendi A. Evanoff, Michelle Alonso-Basanta, L. Dade Lunsford, Jason P. Sheehan

Clinical Study

Malignant brainstem gliomas in adults: clinicopathological characteristics and prognostic factors

Ranjith Babu, Peter G. Kranz, Vijay Agarwal, Roger E. McLendon, Steven Thomas, Allan H. Friedman, Darell D. Bigner, Cory Adamson

Clinical Study

The relationship between working memory and cerebral white matter volume in survivors of childhood brain tumors treated with conformal radiation therapy

Lisa M. Jacola, Jason M. Ashford, Wilburn E. Reddick, John O. Glass, Robert J. Ogg, Thomas E. Merchant, Heather M. Conklin

Clinical Study

Identifying the survival subtypes of glioblastoma by quantitative volumetric analysis of MRI

Zhe Zhang, Haihui Jiang, Xuzhu Chen, Jiwei Bai, Yong Cui, Xiaohui Ren, Xiaolin Chen, Junmei Wang, Wei Zeng, Song Lin

Letter to the Editor

Methylation of the hTERT promoter is frequent in choroid plexus tumors but not of independent prognostic value

Vincent Ruland, Stefan Hartung, Uwe Kordes, Johannes E. Wolff, Werner Paulus, Martin Hasselblatt

Letter to the Editor

The successful treatment of a recurrent intracranial, dural-based plasmacytoma with lenalidomide

Craig E. Devoe, Jian Yi Li, Alexis M. Demopoulos

Erratum

Erratum to: Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas

Kathleen Dorris, Matthew Sobo, Arzu Onar-Thomas, Eshini Panditharatna, Charles B. Stevenson, Sharon L. Gardner, Mariko D. DeWire, Christopher R. Pierson, Randal Olshefski, Sandra A. Rempel, Stewart Goldman, Lili Miles, Maryam Fouladi, Rachid Drissi

Erratum

Erratum to: TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas

Emeline Gillet, Agusti Alentorn, Brahima Doukouré, Emeline Mundwiller, Hinke F. van Thuijl, Jaap C. Reijneveld, José Alfonso Meza Medina, Amélie Liou, Yannick Marie, Karima Mokhtari, Khê Hoang-Xuan, Marc Sanson, Jean-Yves Delattre, Ahmed Idbaih

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.